| Prediction of homoprotein and heteroprotein complexes by protein docking and template‐based modeling: a CASP‐CAPRI experiment MF Lensink, S Velankar, A Kryshtafovych, SY Huang, ... Proteins: Structure, Function, and Bioinformatics 84, 323-348, 2016 | 165 | 2016 |
| Community‐wide evaluation of methods for predicting the effect of mutations on protein–protein interactions R Moretti, SJ Fleishman, R Agius, M Torchala, PA Bates, PL Kastritis, ... Proteins: Structure, Function, and Bioinformatics 81 (11), 1980-1987, 2013 | 111 | 2013 |
| Blind prediction of interfacial water positions in CAPRI MF Lensink, IH Moal, PA Bates, PL Kastritis, ASJ Melquiond, E Karaca, ... Proteins: Structure, Function, and Bioinformatics 82 (4), 620-632, 2014 | 61 | 2014 |
| Structural basis for the recruitment and activation of the Legionella phospholipase VipD by the host GTPase Rab5 M Lucas, AH Gaspar, C Pallara, AL Rojas, J Fernández-Recio, ... Proceedings of the National Academy of Sciences 111 (34), E3514-E3523, 2014 | 56 | 2014 |
| Structural Basis for Rab1 De-AMPylation by the Legionella pneumophila Effector SidD Y Chen, I Tascón, MR Neunuebel, C Pallara, J Brady, LN Kinch, ... PLoS pathogens 9 (5), e1003382, 2013 | 38 | 2013 |
| Intrinsically active MEK variants are differentially regulated by proteinases and phosphatases M Ordan, C Pallara, G Maik-Rachline, T Hanoch, FL Gervasio, F Glaser, ... Scientific reports 8 (1), 11830, 2018 | 31 | 2018 |
| Tetramerization-defects of p53 result in aberrant ubiquitylation and transcriptional activity V Lang, C Pallara, A Zabala, S Lobato-Gil, F Lopitz-Otsoa, R Farrás, ... Molecular oncology 8 (5), 1026-1042, 2014 | 29 | 2014 |
| Expanding the frontiers of protein–protein modeling: from docking and scoring to binding affinity predictions and other challenges C Pallara, B Jiménez‐García, L Pérez‐Cano, M Romero‐Durana, ... Proteins: Structure, Function, and Bioinformatics 81 (12), 2192-2200, 2013 | 26 | 2013 |
| Structural prediction of protein–protein interactions by docking: Application to biomedical problems D Barradas-Bautista, M Rosell, C Pallara, J Fernández-Recio Advances in protein chemistry and structural biology 110, 203-249, 2018 | 21 | 2018 |
| pyDock scoring for the new modeling challenges in docking: Protein–peptide, homo‐multimers, and domain–domain interactions C Pallara, B Jiménez‐García, M Romero, IH Moal, J Fernández‐Recio Proteins: Structure, Function, and Bioinformatics 85 (3), 487-496, 2017 | 21 | 2017 |
| Conformational heterogeneity of unbound proteins enhances recognition in protein–protein encounters C Pallara, M Rueda, R Abagyan, J Fernández-Recio Journal of Chemical Theory and Computation 12 (7), 3236-3249, 2016 | 17 | 2016 |
| Interaction of photosystem I from Phaeodactylum tricornutum with plastocyanins as compared with its native cytochrome c6: reunion with a lost donor P Bernal-Bayard, C Pallara, MC Castell, FP Molina-Heredia, ... Biochimica et Biophysica Acta (BBA)-Bioenergetics 1847 (12), 1549-1559, 2015 | 15 | 2015 |
| Molecular basis for the protective effects of low-density lipoprotein receptor-related protein 1 (LRP1)-derived peptides against LDL aggregation A Benitez-Amaro, C Pallara, L Nasarre, A Rivas-Urbina, S Benitez, A Vea, ... Biochimica et Biophysica Acta (BBA)-Biomembranes 1861 (7), 1302-1316, 2019 | 12 | 2019 |
| Modeling binding affinity of pathological mutations for computational protein design M Romero-Durana, C Pallara, F Glaser, J Fernández-Recio Computational Protein Design, 139-159, 2017 | 5 | 2017 |
| Characterization of p38α autophosphorylation inhibitors that target the non-canonical activation pathway L González, L Díaz, J Pous, B Baginski, A Duran-Corbera, M Scarpa, ... Nature Communications 14 (1), 3318, 2023 | 4 | 2023 |
| Development of Innovative Antiatherosclerotic Peptides through the Combination of Molecular Modeling and a Dual (Biochemical‐Cellular) Screening System A Benitez‐Amaro, C Pallara, L Nasarre, R Ferreira, D de Gonzalo‐Calvo, ... Advanced Therapeutics 3 (8), 2000037, 2020 | 3 | 2020 |
| Peptidomimetics designed to bind to RAS effector domain are promising cancer therapeutic compounds C Pallara, D Cabot, J Rivas, S Brun, J Seco, B Abuasaker, T Tarragó, ... Scientific Reports 12 (1), 15810, 2022 | 2 | 2022 |
| Characterization of p38α autophosphorylation inhibitors that target the non-canonical activation pathway L Díaz, J Pous, B Baginski, A Duran-Corbera, M Scarpa, I Brun-Heath, ... Nature Publishing Group, 2023 | | 2023 |
| Vascular cholesterol inhibitors and use thereof MTT Clua, RP Cosano, C Pallara, VL CORTÉS US Patent App. 17/609,118, 2022 | | 2022 |
| Characterization of cholesteryl ester-loaded human coronary vascular smooth muscle cell secretome. A source of potential biomarkers of coronary artery disease JEG Rodríguez, AB Amaro, L Claudi, J Ni, C Pallara, R Prades, T Tarrago, ... Atherosclerosis 331, e67-e68, 2021 | | 2021 |
